NCT04761900View on ClinicalTrials.gov

MAFLD-simplified Definition as an Optimized Risk Stratification Tool for Predicting Metabolic Outcomes

CompletedOBSERVATIONAL

Enrollment

3,372

Participants

Timeline

Start Date

January 1, 2012

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2020

Conditions

Metabolic Associated Fatty Liver Disease

Interventions

DIAGNOSTIC_TEST

the differences of MAFLD and MAFLD-simplified definitions were compared in predicting metabolic diseases

All Listed Sponsors

lead

Ningbo No. 1 Hospital

OTHER

NCT04761900 - MAFLD-simplified Definition as an Optimized Risk Stratification Tool for Predicting Metabolic Outcomes | Biotech Hunter | Biotech Hunter